What is next-generation sequencing (NGS)?

Next-generation sequencing (NGS) is a high-throughput method used to obtain the sequence of nucleotides in entire genomes or specific gene regions. The technology is becoming more affordable and accessible for many, holding great potential to revolutionise healthcare through clinical applications such as non-invasive prenatal testing (NIPT), to detect cancer mutations for disease diagnosis and treatment decisions, genetic testing and infectious disease testing.

Clearstate offers market data, forecasts, and trend predictions to give you the insight on the NGS market which is set to be the fastest-growing IVD market segment in many countries. 

next-generation sequencing updates by Clearstate

NGS updates

Our NGS hub is regularly updated to share our findings on this emerging IVD market segment. Explore the latest in NGS market developments driving the rapid growth of NGS adoption. Understand the impact of the emergence of NGS on the use of other competing diagnostic technologies in molecular and tissue diagnostics, and examine the challenges to implementing NGS at a wider scale in healthcare, including at smaller laboratories.

Discover more IVD insights or learn how our IVD Gateway solution can help prepare your business for the expanding role of NGS in clinical diagnostics. 

Explore how Clearstate can enable your business to enter and grow as a key player in the market, inquire now.

Explore the latest NGS market insights

From market news to analysis, our articles provide concise and up-to-date information about the developments driving the NGS market. Uncover the challenges and opportunities ahead as the technology triggers a shift in healthcare and clinical diagnosis.

Learn from leading experts and analysts, and see real-world examples of laboratories and healthcare professionals using NGS technology to power deeper clinical insights.

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.